Deborah A. Griffin, Chief Accounting Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 944 shares at $7.16 ($7K) on 2020-03-17, disclosed to the SEC on 2020-03-19.
Open-market sale of $7k TEVA by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TEVA | SELL | 2019-09-20 | $19K | — | Filing → |
| TEVA | SELL | 2019-03-19 | $16K | — | Filing → |
| TEVA | SELL | 2019-03-14 | $15K | — | Filing → |